Your browser doesn't support javascript.
loading
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019.
Gillessen, Silke; Attard, Gerhardt; Beer, Tomasz M; Beltran, Himisha; Bjartell, Anders; Bossi, Alberto; Briganti, Alberto; Bristow, Rob G; Chi, Kim N; Clarke, Noel; Davis, Ian D; de Bono, Johann; Drake, Charles G; Duran, Ignacio; Eeles, Ros; Efstathiou, Eleni; Evans, Christopher P; Fanti, Stefano; Feng, Felix Y; Fizazi, Karim; Frydenberg, Mark; Gleave, Martin; Halabi, Susan; Heidenreich, Axel; Heinrich, Daniel; Higano, Celestia Tia S; Hofman, Michael S; Hussain, Maha; James, Nicolas; Kanesvaran, Ravindran; Kantoff, Philip; Khauli, Raja B; Leibowitz, Raya; Logothetis, Chris; Maluf, Fernando; Millman, Robin; Morgans, Alicia K; Morris, Michael J; Mottet, Nicolas; Mrabti, Hind; Murphy, Declan G; Murthy, Vedang; Oh, William K; Ost, Piet; O'Sullivan, Joe M; Padhani, Anwar R; Parker, Chris; Poon, Darren M C; Pritchard, Colin C; Reiter, Robert E.
Afiliação
  • Gillessen S; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Universita della Svizzera Italiana, Lugano, Switzerland; Cantonal Hospital, St. Gallen, Switzerland; University of Bern, Bern, Switzerland; Division of Cancer Science, University of Manchester, Manchester, UK. Electronic address: s
  • Attard G; University College London Cancer Institute, London, UK.
  • Beer TM; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
  • Beltran H; Dana-Farber Cancer Institute, Boston, MA, USA; Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Bjartell A; Department of Urology, Skåne University Hospital, Malmö, Sweden.
  • Bossi A; Genito Urinary Oncology, Prostate Brachytherapy Unit, Goustave Roussy, Paris, France.
  • Briganti A; Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy.
  • Bristow RG; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK; Christie NHS Trust, Manchester, UK; CRUK Manchester Institute and Cancer Centre, Manchester, UK.
  • Chi KN; BC Cancer, Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada.
  • Clarke N; The Christie and Salford Royal Hospitals, Manchester, UK.
  • Davis ID; Monash University and Eastern Health, Victoria, Australia.
  • de Bono J; The Institute of Cancer Research/Royal Marsden NHS Foundation Trust, Surrey, UK.
  • Drake CG; Division of Haematology/Oncology, Columbia University Medical Center, New York, NY, USA.
  • Duran I; Department of Medical Oncology, Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Cantabria, Spain.
  • Eeles R; The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK.
  • Efstathiou E; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Evans CP; University of California Davis School of Medicine, Sacramento, CA, USA.
  • Fanti S; Policlinico S.Orsola, Università di Bologna, Italy.
  • Feng FY; University of California San Francisco, San Francisco, CA, USA.
  • Fizazi K; Institut Gustave Roussy, University of Paris Sud, Villejuif, France.
  • Frydenberg M; Department of Surgery, Monash University, Melbourne, Australia; Prostate Cancer Research Program, Monash University, Melbourne, Australia; Department Anatomy & Developmental Biology, Faculty of Nursing, Medicine & Health Sciences, Monash University, Melbourne, Australia.
  • Gleave M; Urological Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada.
  • Halabi S; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA.
  • Heidenreich A; Department of Urology, Uro-Oncology, Robot-Assisted and Reconstructive Urology, University of Cologne, Cologne, Germany; Department of Urology, Medical University, Vienna, Austria.
  • Heinrich D; Department of Oncology, Akershus University Hospital, Lørenskog, Norway.
  • Higano CTS; University of Washington, Seattle, WA, USA; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Hofman MS; Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.
  • Hussain M; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.
  • James N; The Institute of Cancer Research, London, UK.
  • Kanesvaran R; Division of Medical Oncology, National Cancer Centre, Singapore.
  • Kantoff P; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA.
  • Khauli RB; Department of Urology, American University of Beirut Medical Center, Beirut, Lebanon; Naef K. Basile Cancer Institute (NKBCI), American University of Beirut Medical Center, Beirut, Lebanon.
  • Leibowitz R; Oncology institute, Shamir Medical Center and Faculty of medicine, Tel-Aviv University, Israel.
  • Logothetis C; Department of Genitourinary Medical Oncology, MD Anderson Cancer Centre, Houston, TX, USA; Department of Clinical Therapeutics, David H. Koch Centre, University of Athens Alexandra Hospital, Athens, Greece.
  • Maluf F; Beneficiência Portuguesa de São Paulo, São Paulo, SP, Brazil; Departamento de Oncologia, Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
  • Millman R; UK.
  • Morgans AK; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.
  • Morris MJ; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Mottet N; University Hospital Nord, St Etienne, France.
  • Mrabti H; National Institute of Oncology, University hospital, Rabat, Morocco.
  • Murphy DG; Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.
  • Murthy V; Tata Memorial Centre, Mumbai, India.
  • Oh WK; Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, The Tisch Cancer Institute, New York, NY, USA.
  • Ost P; Radiation Oncology, Ghent University Hospital, Ghent, Belgium.
  • O'Sullivan JM; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland, UK; Radiotherapy Department, Cancer Centre, Belfast City Hospital, Belfast, Northern Ireland, UK.
  • Padhani AR; Mount Vernon Cancer Centre and Institute of Cancer Research, London, UK.
  • Parker C; Royal Marsden Hospital and Institute of Cancer Research, Sutton, UK.
  • Poon DMC; Comprehensive Oncology Centre, Hong Kong Sanatorium & Hospital, The Chinese University of Hong Kong, Hong Kong.
  • Pritchard CC; Department of Laboratory Medicine, University of Washington, Seattle, WA, USA.
  • Reiter RE; University of California Los Angeles, Los Angeles, CA, USA.
Eur Urol ; 77(4): 508-547, 2020 04.
Article em En | MEDLINE | ID: mdl-32001144
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata Tipo de estudo: Guideline / Prognostic_studies Limite: Humans / Male Idioma: En Revista: Eur Urol Ano de publicação: 2020 Tipo de documento: Article País de publicação: Suíça
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata Tipo de estudo: Guideline / Prognostic_studies Limite: Humans / Male Idioma: En Revista: Eur Urol Ano de publicação: 2020 Tipo de documento: Article País de publicação: Suíça